A Case Report on Post-haemodialysis Pyrexia Caused due to a Rare Species of Trichosporon
Published: November 1, 2025 | DOI: https://doi.org/10.7860/JCDR/2025/81615.21976
Aman Kumar Gupta, Sourya Acharya, Sunil Kumar, Dipika Shaw, Anjali Patond
1. Junior Resident, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
2. Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
3. Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
4. Assistant Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
5. Assistant Professor, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha, Maharashtra, India.
Correspondence
Dr. Aman Kumar Gupta,
Junior Resident, Department of Medicine, DMIHER, Sawangi, Meghe, Wardha-442001, Maharashtra, India.
E-mail: amangupta1907@gmail.com
Hypertension is a global health threat, which, in coexistence with chronic kidney disease, increases the associated health risks. Most of the vulnerable patients receive prophylactic therapeutic intervention for fungal infections, though, in a few instances, there is a delay in symptomatic presentation. The patients with hypertension and chronic kidney disease receiving haemodialysis should be monitored strictly for the same. This is a case of a 41-year-old male infected with Trichosporon infection with a positive history of hypertension and chronic kidney disease, receiving haemodialysis treatment. The patient was timely confirmed to have the diagnosis and successfully managed with the systemic antifungal drug Itraconazole {100 mg (BD) for 14 days} and Fluoroquinolones {500 mg (OD) for seven days}. A follow-up at one month showed the patient with laboratory markers within normal limits.
[
FULL TEXT ] | [ PDF]